Suppr超能文献

核医学程序中的归因患者风险和诊断参考水平的建立。

Attributable patient risk in nuclear medicine procedures and establishment of diagnostic reference levels.

机构信息

Instituto de Radioproteção e Dosimetria (DIFME/IRD/CNEN), Rio de Janeiro, Brazil.

Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.

出版信息

J Appl Clin Med Phys. 2023 Jan;24(1):e13658. doi: 10.1002/acm2.13658. Epub 2022 Dec 28.

Abstract

The assessment of risk related to medical exposures as a justification tool to assist decision-making of the medical team is not available in clinical routine. The determination of diagnostic reference levels (DRLs) for nuclear medicine (NM) procedures has been proposed as an optimization tool, but this tool has still been aimed at a standard adult individual. It is known that the activity administered, and the consequent absorbed doses in critical organs, represents the risk of a procedure being cancer induction the greatest concern, especially for young patients. Thus, the adjustment of administered activity and procedure risk to promote risk-benefit assessment is a promising tool for routine clinical use. This work aims to present a tool for determining DRLs in the administered activity related to the patient's characteristics-age group, sex, and body mass index (BMI), in order to assist the medical decision regarding the risk-benefit ratio. Thus, it is possible to assess the risk of carcinogenesis in groups of patients, considering absorbed doses in organs, cancer incidence, and mortality rates in our country. NIREA is an IT tool developed in PHP language for web environment as a friendly software. It allows the establishment of DRL and risk of cancer induced by radiation assessment through the estimation of absorbed doses in specific organs and based on the risk methodology of BEIR VII. The absorbed and effective doses were estimated based on the dose conversion factors of the radiopharmaceuticals published by the International Commission on Radiological Protection adjusted for the patient groups. Based on data from 2256 patients who underwent diagnostic procedures at National Cancer Institute between 2017 and 2019, the program was used, resulting in important information for conducting the clinical routine extracted as DRL, absorbed doses, and risk assessments, considering patient-specific data such as age, sex, and BMI. The methodology developed in this work allows NM services to keep their data available and updated regarding local DRLs, in addition to allowing the nuclear physician to know the risk of each procedure performed, extracted by individual characteristics of the patient. The affirmative is significant because the data could be used by the regulatory body of practices with ionizing radiation in Brazil to establish a reference level in Activity that has not yet existed in the country.

摘要

将医疗照射风险评估作为协助医疗团队决策的工具,目前尚未在临床常规中应用。核医学(NM)程序的诊断参考水平(DRL)的确定已被提议作为一种优化工具,但该工具仍针对标准成年人个体。已知,所给予的放射性活度以及由此导致的关键器官吸收剂量,是程序致癌风险的最大关注点,尤其是对于年轻患者而言。因此,调整所给予的放射性活度和程序风险以促进风险效益评估,是常规临床应用的有前途的工具。本工作旨在提出一种用于确定与患者特征(年龄组、性别和体重指数(BMI))相关的给予放射性活度的 DRL 的工具,以协助医疗决策关于风险效益比。因此,可以评估考虑器官吸收剂量、癌症发病率和我国死亡率的患者群体的致癌风险。NIREA 是一种在 PHP 语言中开发的 IT 工具,用于网络环境,是一款友好的软件。它允许通过估计特定器官的吸收剂量并基于 BEIR VII 的风险方法,来建立 DRL 和由辐射引起的癌症风险。吸收剂量和有效剂量是根据国际辐射防护委员会发布的放射性药物剂量转换系数估算的,并针对患者群体进行了调整。基于 2017 年至 2019 年期间在国家癌症研究所进行诊断程序的 2256 名患者的数据,使用了该程序,提取了考虑患者年龄、性别和 BMI 等个体特征的 DRL、吸收剂量和风险评估等重要信息。本工作中开发的方法学允许 NM 服务保持其数据可用且与本地 DRL 更新,此外还允许核医师了解所执行的每个程序的风险,这些风险是根据患者的个体特征提取的。这一方法具有重要意义,因为巴西电离辐射实践的监管机构可以使用这些数据来建立该国目前尚未存在的活动参考水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fc/9859988/c9ca88c180c9/ACM2-24-e13658-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验